New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on ACELYRIN, INC. (SLRN – Research Report). The company’s ...

Derek Archila, an analyst from Wells Fargo, maintained the Buy rating on ACELYRIN, INC. (SLRN – Research Report). The associated price target ...

Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show gains.

AxSpA can bring on plantar fasciitis, which is when inflammation in the heel causes the sole of your foot to hurt. You may ...

MRT-6160 is under development for the treatment of axial spondyloarthritis, rheumatoid arthritis, multiple sclerosis, Myasthenia Gravis, psoriasis, cutaneous lupus erythematosus a ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Upadacitinib vs placebo demonstrated lasting efficacy and safety over 52-weeks of treatment among patients with nr-axSpA.

Alcohol consumption was associated with lower levels of axSpA disease activity and spinal pain, but may be linked to ...

TNF inhibitors offered greater protection against fractures than NSAIDs in patients with axial spondyloarthritis (axSpA).

Study finds TNF inhibitors lower hip and spine fracture risk in axial spondyloarthritis, addressing inflammation-related ...

High-dose nonsteroidal anti-inflammatory drug use among patients with axial spondyloarthritis (axSpA) may not increase the risk of developing hypertension, according to study results presented at the ...